. .
.
. Mayo Clinic Health Solutions
.
. .
.

Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

mMBP-1 deficient Mice

Reference #:

1998-039

Inventors/Contributors

James J. Lee, M.D., Ph.D., Nancy A. Lee, M.D., Ph.D.

Description

Through the use of gene targeting in mouse embryonic stem (ES) cells we have sucessfully generated a line of mice deficient in eosinophil granule major basic protein-1 (mMBP-1). These mice would be useful in drug discovery programs directed toward developing treatments for asthma, allergy, inflammation and a variety of eosinophil-related disorders.

Patent Status

button

U.S. Patent Number 6,177,610
Issued January 23, 2001

Contact

Julie A. Henry, Licensing Manager
henry.julie@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 266-4585
Fax: (507) 284-5410